Nanotechnology Now - News Story: pSivida's BioSilicon(TM) Demonstrates Adjuvant Properties

Home > News > pSivida's BioSilicon(TM) Demonstrates Adjuvant Properties

July 5th, 2006

pSivida's BioSilicon(TM) Demonstrates Adjuvant Properties

Abstract:
Global bio-nanotech company pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI) today announced that its novel drug delivery platform, BioSilicon(TM) has demonstrated the capability to act as an adjuvant when delivered with an antigen.

Source:
businesswire

Bookmark:

Related News Press

Nanomedicine

Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025

Next-generation drug delivery innovation! DGIST develops precision therapeutics using exosomes April 25th, 2025

Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025

Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025

Announcements

Portable Raman analyzer detects hydrogen leaks from a distance: Device senses tiny concentration changes of hydrogen in ambient air, offering a dependable way to detect and locate leaks in pipelines and industrial systems April 25th, 2025

Enhancing power factor of p- and n-type single-walled carbon nanotubes April 25th, 2025

Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025

Ultrafast plasmon-enhanced magnetic bit switching at the nanoscale April 25th, 2025

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE